Cargando…
Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal adverse event associated with the use of antipsychotics. Although atypical antipsychotics were initially considered to carry no risk of NMS, reports have accumulated over time implicating them in NMS causation. Almost all atypical...
Autores principales: | Sarkar, Siddharth, Gupta, Nitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Psychiatrists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537576/ https://www.ncbi.nlm.nih.gov/pubmed/28811916 http://dx.doi.org/10.1192/pb.bp.116.053736 |
Ejemplares similares
-
CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002) -
Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013) -
Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant
Antipsychotics
por: Ramadas, Smitha, et al.
Publicado: (2022) -
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006) -
The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome
por: Kyotani, Yoji, et al.
Publicado: (2023)